Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopkins ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.

May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigational ...
May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitoring ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

May 15, 2017 – The Heart Rhythm Society (HRS) in joint partnership with several other electrophysiology societies issued ...
May 12, 2017 — More than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) were observed to ...
May 10, 2017 — Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
May 2, 2017 — Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole ...
April 25, 2017 — AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion System ...
May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
April 10, 2017 — Medtronic recently announced the first enrollments in the STOP Persistent AF clinical trial. The study ...

March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial ...

March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
March 22, 2017 — Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval ...
March 14, 2017 — More than 80 percent of stroke patients with a history of atrial fibrillation either received not ...
February 16, 2017 — Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cr ...